SNS Insider reports that the global chlamydia infection treatment market was valued at USD 3.83 billion in 2023 and is forecasted to reach USD 8.09 billion by 2031. This growth represents a compound annual growth rate (CAGR) of 9.81% during the forecast period from 2024 to 2031.
The Irritable Bowel Syndrome (IBS) Treatment Market, valued at USD 1.47 billion in 2022, is projected to...